It is also important to note that EG00229 exhibited minimal effects on parental cells, but in cells that exhibited acquired resistance to targeted therapies, Nrp1 knock down and EG00229 treatment were sufficient to resensitize tumor cells to the targeted therapies (90). This evidence concerns the gene NRP1 and neoplasm.